scholarly journals Author Correction: A 1-minute blood test detects decreased immune function and increased clinical risk in COVID-19 patients

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Chirajyoti Deb ◽  
Allan N. Salinas ◽  
Tianyu Zheng ◽  
Aurea Middleton ◽  
Katelyn Kern ◽  
...  
2021 ◽  
Author(s):  
Chirajyoti Deb ◽  
Allan Salinas ◽  
Tianyu Zheng ◽  
Aurea Middleton ◽  
Katelyn Kern ◽  
...  

Abstract Upon infection with SARS-CoV-2, the virus that causes COVID-19, most people will develop no or mild symptoms. However, a small percentage of the population will become severely ill, and some will succumb to death. The clinical severity of COVID-19 has a close connection to the dysregulation of the patient’s immune functions. We previously developed a simple, nanoparticle-enabled blood test that can determine the humoral immune status in animals. In this study, we applied this new test to analyze the immune function in relation to disease severity in COVID-19 patients. From the testing of 153 COVID-19 patient samples and 142 negative controls, we detected a drastic decrease of humoral immunity in COVID-19 patients who developed moderate to severe symptoms, but not in patients with no or mild symptoms. The new test may be potentially used to monitor the immunity change and predict the clinical risk of patients with COVID-19.


2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Chirajyoti Deb ◽  
Allan N. Salinas ◽  
Tianyu Zheng ◽  
Aurea Middleton ◽  
Katelyn Kern ◽  
...  

AbstractUpon infection with SARS-CoV-2, the virus that causes COVID-19, most people will develop no or mild symptoms. However, a small percentage of the population will become severely ill, and some will succumb to death. The clinical severity of COVID-19 has a close connection to the dysregulation of the patient’s immune functions. We previously developed a simple, nanoparticle-enabled blood test that can determine the humoral immune status in animals. In this study, we applied this new test to analyze the immune function in relation to disease severity in COVID-19 patients. From the testing of 153 COVID-19 patient samples and 142 negative controls, we detected a drastic decrease of humoral immunity in COVID-19 patients who developed moderate to severe symptoms, but not in patients with no or mild symptoms. The new test may be potentially used to monitor the immunity change and predict the clinical risk of patients with COVID-19.


PLoS Medicine ◽  
2021 ◽  
Vol 18 (8) ◽  
pp. e1003728
Author(s):  
Brian D. Nicholson ◽  
Paul Aveyard ◽  
Constantinos Koshiaris ◽  
Rafael Perera ◽  
Willie Hamilton ◽  
...  

Background Unexpected weight loss (UWL) is a presenting feature of cancer in primary care. Existing research proposes simple combinations of clinical features (risk factors, symptoms, signs, and blood test data) that, when present, warrant cancer investigation. More complex combinations may modify cancer risk to sufficiently rule-out the need for investigation. We aimed to identify which clinical features can be used together to stratify patients with UWL based on their risk of cancer. Methods and findings We used data from 63,973 adults (age: mean 59 years, standard deviation 21 years; 42% male) to predict cancer in patients with UWL recorded in a large representative United Kingdom primary care electronic health record between January 1, 2000 and December 31, 2012. We derived 3 clinical prediction models using logistic regression and backwards stepwise covariate selection: Sm, symptoms-only model; STm, symptoms and tests model; Tm, tests-only model. Fifty imputations replaced missing data. Estimates of discrimination and calibration were derived using 10-fold internal cross-validation. Simple clinical risk scores are presented for models with the greatest clinical utility in decision curve analysis. The STm and Tm showed improved discrimination (area under the curve ≥ 0.91), calibration, and greater clinical utility than the Sm. The Tm was simplest including age-group, sex, albumin, alkaline phosphatase, liver enzymes, C-reactive protein, haemoglobin, platelets, and total white cell count. A Tm score of 5 balanced ruling-in (sensitivity 84.0%, positive likelihood ratio 5.36) and ruling-out (specificity 84.3%, negative likelihood ratio 0.19) further cancer investigation. A Tm score of 1 prioritised ruling-out (sensitivity 97.5%). At this threshold, 35 people presenting with UWL in primary care would be referred for investigation for each person with cancer referred, and 1,730 people would be spared referral for each person with cancer not referred. Study limitations include using a retrospective routinely collected dataset, a reliance on coding to identify UWL, and missing data for some predictors. Conclusions Our findings suggest that combinations of simple blood test abnormalities could be used to identify patients with UWL who warrant referral for investigation, while people with combinations of normal results could be exempted from referral.


2008 ◽  
Vol 39 (5) ◽  
pp. 1-8
Author(s):  
BRUCE JANCIN
Keyword(s):  

2005 ◽  
Vol 38 (1) ◽  
pp. 16
Author(s):  
BRUCE JANCIN
Keyword(s):  

2010 ◽  
Vol 43 (13) ◽  
pp. 61
Author(s):  
SARA FREEMAN
Keyword(s):  

2007 ◽  
Vol 6 (1) ◽  
pp. 46-46
Author(s):  
L FRANKENSTEIN ◽  
L INGLE ◽  
A REMPPIS ◽  
D SCHELLBERG ◽  
C SIGG ◽  
...  

1999 ◽  
Author(s):  
Ted Robles ◽  
Jessica Malmstadt ◽  
Jon Kabat-Zinn ◽  
Daniel Muller ◽  
Richard Davidson

Sign in / Sign up

Export Citation Format

Share Document